Showing results (341-350 of 563) with videos related to
Sort By:
Pageof 57
European Urology|May 20, 2004
Evaluation of the clinical benefit of permixon and tamsulosin in severe BPH patients-PERMAL study subset analysisFrans Debruyne, Peter Boyle, Fernando Calais Da Silva, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2010
Subcutaneous compared with intravenous administration of amifostine in patients with head and neck cancer receiving radiotherapy: final results of the GORTEC2000-02 phase III randomized trialEtienne Bardet, Laurent Martin, Gilles Calais, et al.BMC Cancer|May 8, 2021
Phase 3 multicenter randomized trial of PSMA PET/CT prior to definitive radiation therapy for unfavorable intermediate-risk or high-risk prostate cancer [PSMA dRT]: study protocolJeremie Calais, Shaojun Zhu, Nader Hirmas, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 30, 2024
FAP and PSMA Expression by Immunohistochemistry and PET Imaging in Castration-Resistant Prostate Cancer: A Translational Pilot StudyRong Rong Huang, Chunlai Zuo, Christine E Mona, et al.Anticancer Research|December 31, 2021
Prognostic Impact of Upfront Surgery for Locally Advanced Upper Rectal AdenocarcinomaOlivier Muller, Remy Sindayigaya, Sandra Chomicki, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 3, 2012
Intensity-modulated radiotherapy in head and neck cancer: results of the prospective study GORTEC 2004-03Ivan Toledano, Pierre Graff, Antoine Serre, et al.European Journal of Cancer (Oxford, England : 1990)|April 18, 2012
What is the clinical benefit of preoperative chemoradiotherapy with 5FU/leucovorin for T3-4 rectal cancer in a pooled analysis of EORTC 22921 and FFCD 9203 trials: surrogacy in question?F Bonnetain, J F Bosset, J P Gerard, et al.Current Treatment Options in Oncology|January 25, 2024
Impact of PSMA PET on Prostate Cancer ManagementAdam B Weiner, Raag Agrawal, Luca F Valle, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 1, 2024
Prostate-Specific Membrane Antigen PET/CT-Guided, Metastasis-Directed Radiotherapy for Oligometastatic Castration-Resistant Prostate CancerJohn Nikitas, Angela Castellanos Rieger, Andrea Farolfi, et al.International Journal of Radiation Oncology, Biology, Physics|April 24, 2007
Does concurrent radiochemotherapy affect cosmetic results in the adjuvant setting after breast-conserving surgery? Results of the ARCOSEIN multicenter, Phase III study: patients' and doctors' viewsAlain H Toledano, Marc A Bollet, Alain Fourquet, et al.Pageof 57